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Background. Inﬂuenza data gaps in sub-Saharan Africa include incidence, case fatality, seasonal patterns, and
associations with prevalent disorders.
Methods. Nasopharyngeal samples from children aged <12 years who were admitted to Kiliﬁ District Hospital
during 2007–2010 with severe or very severe pneumonia and resided in the local demographic surveillance system
were screened for inﬂuenza A, B, and C viruses by molecular methods. Outpatient children provided comparative data.
Results. Of 2002 admissions, inﬂuenza A virus infection was diagnosed in 3.5% (71), inﬂuenza B virus infection,
in 0.9% (19); and inﬂuenza C virus infection, in 0.8% (11 of 1404 tested). Four patients with inﬂuenza died. Among
outpatients, 13 of 331 (3.9%) with acute respiratory infection and 1 of 196 without acute respiratory infection were
inﬂuenza positive. The annual incidence of severe or very severe pneumonia, of inﬂuenza (any type), and of inﬂuenza
A, was 1321, 60, and 43 cases per 100 000 <5 years of age, respectively. Peak occurrence was in quarters 3–4 each year,
and approximately 50% of cases involved infants: temporal association with bacteremia was absent. Hypoxia was more
frequent among pneumonia cases involving inﬂuenza (odds ratio, 1.78; 95% conﬁdence interval, 1.04–1.96). Inﬂuenza
A virus subtypes were seasonal H3N2 (57%), seasonal H1N1 (12%), and 2009 pandemic H1N1 (7%).
Conclusions. The burden of inﬂuenza was small during 2007–2010 in this pediatric hospital in Kenya. Inﬂuenza
A virus subtype H3N2 predominated, and 2009 pandemic inﬂuenza A virus subtype H1N1 had little impact.
A recent review of seasonal inﬂuenza during 1998–
2009 revealed a paucity of epidemiological data
throughout most of sub-Saharan Africa, including
Kenya [1]. In particular, there were few inﬂuenza-
associated data on age-speciﬁc incidence, mortality,
seasonal variation, and relationship with common co-
occurring conditions, including human immunodeﬁ-
ciency virus (HIV) infection, malnutrition, bacterial
pneumonia, and malaria. In this study, we report the
results of surveillance for inﬂuenza among patients
presenting to a rural district hospital and outpatient
clinics in coastal Kenya during 2007–2010. We used
molecular diagnostic methods to distinguish inﬂuenza
A, B, and C viruses and to subtype inﬂuenza A
viruses. At admission to Kiliﬁ District Hospital
(KDH), detailed clinical and laboratory data were sys-
tematically collected, and residency within the sur-
rounding Kiliﬁ Health and Demographic Surveillance
System (KHDSS) was ascertained. The study spans a
period in which a new strain of inﬂuenza A virus,
2009 pandemic inﬂuenza A virus subtype H1N1 (A
[H1N1]pdm09), spread worldwide and entered the
study population, the occurrence of which was moni-
tored through inﬂuenza virus subtyping.
MATERIALS AND METHODS
Study Population and Samples
We sampled children presenting to KDH and sur-
rounding outpatient clinics located in Kiliﬁ District on
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the coast of Kenya, approximately 60 km north of Mombasa.
The district comprises a largely rural population of subsistence
farmers and has an equatorial climate, with rain predominant-
ly falling during April–July and October–December. KDH is
the principal hospital facility for the population of the
KHDSS. Further details of the study area and respiratory
disease surveillance at KDH and local clinics can be found in
previous reports (2–4, 13). Nasopharyngeal wash or aspirate
specimens were collected from eligible children aged 1 day to
12 years from January 2007 through December 2010 and were
either stored in viral transport medium at −80°C (2007–2009)
prior to molecular screening or screened prior to freezing in
raw form.
Inpatients were eligible if they were admitted to the hospital
with cough or difﬁculty breathing and either lower-chest-wall
indrawing (deﬁned as severe pneumonia) or 1 or more of the
following: cyanosis, prostration, unconsciousness, or an
oxygen saturation level <90% (a modiﬁcation of the World
Health Organization criteria for very severe pneumonia). Chil-
dren who were not residing in the KHDSS at admission, were
admitted in extremis, were admitted for elective surgery, or
received a diagnosis of neonatal tetanus were excluded. The
following clinical and laboratory features obtained on admis-
sion or that relate to discharge outcome were compared
between inﬂuenza-positive and inﬂuenza-negative children:
duration of hospitalization >14 days, very severe pneumonia,
wheezing, hypoxia (oxygen saturation level <90%, by ﬁngertip
pulse oximetry), circulatory shock (capillary reﬁll time ≥3
seconds), severe anemia (hemoglobin level <5 g/dL), prematu-
rity, congenital heart disease, positivity for HIV antibody (by
2 rapid tests), severe underweight (weight for age Z score ≤3),
slide positivity for Plasmodium species, bacteremia, concurrent
viral infection diagnosis, and death before discharge [2]. Out-
patient recruits were a convenience sample of children aged
<13 years, enrolled for broad comparison with hospital-
admitted patients, who presented with either no signs of acute
respiratory infection (non-ARI) or signs of upper respiratory
tract infection (URTI) [2, 5]. Individuals with URTI had 1 or
more of the following: cough, difﬁculty breathing, nasal dis-
charge, runny or blocked nose, or sore throat. Written in-
formed consent was obtained from the parent or guardian of
subjects. This study was approved by the Kenyan National
Ethical Review Committee and the University of Warwick Bio-
medical Research Ethics Subcommittee.
Diagnostic Real-Time Reverse-Transcription Polymerase
Chain Reaction (RT-PCR)
RNA was extracted from 140 µL of nasopharyngeal samples,
using the Qiagen Viral RNA miniprep kit (Qiagen, United
Kingdom), or from 200 µL of nasopharyngeal samples, using
the total nucleic acid extraction kit (Roche Applied Science,
Germany) with a MagNA Pure LC32 automated nucleic acid
extractor, following the manufacturer’s instructions. Diagnos-
tic screening for viral targets was performed using real-time
RT-PCR. For specimens from KDH inpatients in 2007 and
from outpatients in 2007–2008, reactions were tested by multi-
plex real-time RT-PCR, using FRET hybridization probes as
described by Lassaunière et al [6], with primers and probe tar-
geting NS1 of inﬂuenza A virus and nucleoprotein of inﬂuenza
B virus. All other samples were screened using the Taqman
Qiagen Quantifast multiplex method on the ABI 7500 plat-
form described by Hammitt et al, targeting the matrix protein
for inﬂuenza A and C viruses and targeting NS for inﬂuenza
B virus [3]. Concurrent targets in both RT-PCR assays includ-
ed respiratory syncytial virus (RSV), adenovirus, rhinovirus,
parainﬂuenza virus (PIV) 1–3, human metapneumovirus, co-
ronavirus (CoV 229e, NL69, and OC43), and, differentially by
assay, coronavirus Hong Kong [6] and PIV4 [3].
Subtype Analysis
An aliquot of each of the inﬂuenza A virus–positive specimens
was shipped to the National Inﬂuenza Center (NIC) in
Nairobi for subtyping. Samples were subjected to RNA extrac-
tion using the QIAamp viral RNA isolation kit (Qiagen). De-
tection was performed using Invitrogen SuperScript III
Platinum One-Step quantitative kit with primers and probes
targeting seasonal inﬂuenza A virus H1N1 (A[H1N1]), A
(H1N1)pdm09, and inﬂuenza A virus subtype H3N2 (A
[H3N2]).
Statistical Analysis
Statistical analysis was undertaken using Stata, version 11.0
(StataCorp, College Station, TX) and Microsoft Ofﬁce Excel
2003 (Microsoft, Redmond, WA). The incidence of inﬂuenza
among inpatients for age group i, I(i), per 100 000 population
per year was estimated on the basis of the equation I(i) = [C
(i)/N(i)p(i)].100,100, where C(i) is the average number of chil-
dren per year admitted who were resident in the KHDSS in
age group i, N(i) the midsurvey KHDSS population in age
group i, and p(i) is the proportion of eligible children tested
for inﬂuenza (ie, we assumed that children who were not
tested would have had the same prevalence of inﬂuenza as
those who were tested and scaled the incidence accordingly).
For pneumonia incidence estimates, p(i) is set to 1. The
KDHSS population on 1 January 2009 was estimated to be
9451 individuals aged <1 year, 45 644 aged <5 years, and
108 708 aged <13 years. The population size and incidence es-
timation procedures have been described elsewhere [4]. The
incidence estimation for the population proximal to the hospi-
tal was undertaken using cases involving children aged <5
years admitted from administrative sublocations within a 5-
km radius of the hospital and the corresponding midpoint
population estimate from the KHDSS (12 339 as of 1 January
2009). The Wilcoxon rank sum test was used to compare
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median ages; the χ2 or Fisher exact test was used to compare
proportions, as appropriate; the Score test (procedure
tabodds) was used to assess the trend in prevalence, by age;
and the Poisson probability distribution was used to assess
whether observed cases of inﬂuenza in speciﬁed quarters of
the year exceeded the expected number of cases. Spearman
rank correlation was used to test for a temporal association
between monthly or quarterly numbers of inﬂuenza cases or
inﬂuenza A virus infections and the number of cases of bacter-
emia or Streptococcus pneumoniae infection. The analysis was
undertaken with cases of inﬂuenza and bacteremia temporally
in phase or between 1 and 4 months time step out of phase.
The association between positivity for any inﬂuenza type and
laboratory or clinical features on admission was assessed using
logistic regression, adjusted for age group, to obtain odds
ratios (ORs) and 95% conﬁdence intervals (95% CIs).
RESULTS
Over the 4-year period, there were 2429 admissions to KDH
involving individuals who were eligible for the study (57%
were boys; median age, 9 months [interquartile range {IQR},
3–22 months]). A total of 503 (21%) had very severe pneumo-
nia (50% were boys; median age, 10 months [IQR, 2–34
months]; 55% were infants), and the in-hospital case-fatality
rate was 6.5%. Of the eligible inpatients, 2002 (82%) were
tested for inﬂuenza (57% were boys; median age, 9 months
[IQR, 3–21 months]; 58% were infants), and this percentage
did not differ among those aged <1 year, 1–4 years, and ≥5
years (P = .333); 387 (19%) had very severe pneumonia (52%
were boys; median age, 10 months [IQR, 2–34 months]; 53%
were infants). Stratiﬁed by severity, 84% of eligible inpatients
with severe pneumonia were tested, compared with 77% of eli-
gible inpatients with very severe pneumonia (P = .001). The
case-fatality rate among inpatients who were untested was sig-
niﬁcantly higher than among those who were tested (69 of 427
[16%] vs 88 of 2002 [4.4%]; P < .0001). Reasons for not testing
comprised consent refusal (63%), early discharge (26%), and
death (11%) before sampling.
Within the same period, 527 outpatients were recruited and
tested for inﬂuenza from May 2007 through March 2008 (57
with non-ARI and 96 with URTI) and again from March 2010
through December 2010 (139 with non-ARI and 235 with
URTI). Cumulative non-ARI cases numbered 15, 40, 76 and 65,
for quarters 1–4, respectively, and cumulative URTI cases num-
bered 47, 95, 99, and 90, respectively. Overall, 196 outpatients
had non-ARI (median age, 13 months [IQR, 5–26 months];
47% were infants), and 331 had URTI (median age, 19 months
[IQR, 8–39 months]; 37% were infants). Compared with the
median age of inpatients, the median ages of outpatients with
non-ARI (P = .004) or URTI (P≤ .0001) were higher.
Prevalence, Disease Association, and Incidence
The prevalence of inﬂuenza virus of any type was 4.9% (99 of
2002 cases) among inpatients; 4.7% (76 of 1615) had severe
pneumonia, and 5.9% (23 of 387) had very severe pneumonia
(P = .299). Among outpatients, the prevalence of inﬂuenza
virus of any type was 3.9% (13 of 331) among those with
URTI and 0.5% (1 of 196) among those with non-ARI. Data
stratiﬁed by virus type are presented in Table 1. Inﬂuenza A
virus was the most prevalent type among outpatients with
pneumonia (3.5%) and outpatients with URTI (3.3%). These
proportions were unaltered by restricting the analysis to chil-
dren <5 years of age. Among outpatients classiﬁed as having
Table 1. Distribution of Inﬂuenza Viruses Diagnosed by Molecular Methods Among Children, by Presenting Condition, From Kiliﬁ,
Kenya, 2007–2010
Condition
No. of Children Influenza Virus Detected, by Type, No. (%b) of Children
Eligible Tested Anya A B Cc
NARI 196 196 1 (0.5) 1 (0.5) 0 0
URTI 331 331 13 (3.9) 11 (3.3) 1 (0.3) 2 (0.9)
Severe pneumonia 1926 1615 76 (4.7) 57 (3.5) 13 (0.8) 7 (0.6)
Very severe pneumonia 503 387 23 (5.9) 14 (3.6) 6 (1.6) 4 (1.4)
All pneumonia (severe and very severe) 2429 2002 99 (4.9) 71 (3.5) 19 (0.9) 11 (0.8)
Total 2956 2529 113 (4.5) 83 (3.3) 20 (0.8) 13 (0.7)
All children resided in the Kilifi Health and Demographic Surveillance System.
Abbreviations: NARI, no acute respiratory infection; URTI, upper respiratory tract infection.
a Includes influenza A, B, or C viruses. There were 13 influenza diagnoses among outpatients with URTI, but 14 influenza viruses were detected because 1 child
was coinfected (with influenza A and C viruses), and there were 99 influenza diagnoses among all inpatients with pneumonia, but 101 influenza viruses were
detected because 2 children were coinfected (with influenza A and B viruses in one and influenza A and C viruses in the other).
b % is number detected / number tested
c Because samples collected during 2007 were not tested for influenza C virus, percentages are based on the following denominators: NARI, 139; URTI, 235;
severe pneumonia, 1126; and very severe pneumonia, 288.
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non-ARI, there were no cases of inﬂuenza B or C virus infec-
tion; inﬂuenza A virus was detected in 1 child.
The estimated incidence of severe or very severe pneumonia
among children <1 year of age, <5 years of age, and <13 years
of age was 3902 (95% CI, 3708–4106), 1321 (95% CI, 1269–
1375), and 589 (95% CI, 567–612) cases per 100 000 popula-
tion per year, respectively. Correspondingly, for all inpatients
with inﬂuenza, the incidence of severe or very severe pneumo-
nia for those aged <1 year, <5 years, and <13 years was 154
(95% CI, 116–204), 60 (95% CI, 49–74), and 28 (95% CI, 23–
34) cases per 100 000 per year, respectively, after scaling for
the proportion of patients who were tested for pneumonia (ie,
0.82). For inpatients with inﬂuenza A virus infection, the inci-
dence of severe or very severe pneumonia among children
aged <1 year, <5 years, and <13 years, was 106 (95% CI, 75–
149), 43 (95% CI, 34–55), and 20 (95% CI, 16–25) cases per
100 000 per year, respectively. Considering only inpatients <5
years of age who were admitted from locations within a 5-km
radius of KDH, the incidence estimates (using a scaling factor,
p, of 0.78) of severe or very severe pneumonia, inﬂuenza, and
inﬂuenza A virus infection were 1815 (95% CI, 1700–1938),
106 (95% CI, 78–144), and 70 (95% CI, 48–102) cases per
100 000 per year, respectively. Comparative estimates of inci-
dence by age group for other virus groups are presented in
Supplementary Table 2. Rhinovirus and RSV infection had
higher incidences than that for inﬂuenza virus by factors of 4–
6 and 5–8, respectively, according to age group.
Distribution of Inﬂuenza Virus Infection, by Season and by
Age
The seasonal patterns of inﬂuenza A and B virus infection are
shown in Figure 1. Over the 4-year period, inﬂuenza A and B
virus infection showed a signiﬁcantly higher occurrence among
inpatients during quarters 3 and 4, relative to the average for all
quarters (22.5 cases expected vs 37.5 cases observed; P = .003).
There was very little inﬂuenza activity in 2010. The majority of
inﬂuenza B virus infections occurred in the fourth quarter of
2009. Most inﬂuenza cases occurred after the main period of
rainfall (April–July) and before peak temperatures (ﬁrst quarter;
Figure 1). Cases of bacteremia, and speciﬁcally S. pneumoniae
infection, by quarter, are shown in Figure 1. No statistically
signiﬁcant correlation between inﬂuenza cases (or inﬂuenza A
virus infections) and occurrence of bacteremia (or S. pneumo-
niae infection) was identiﬁed, either concurrently or delayed
(P > .05).
Of the 70 of 83 inﬂuenza A virus–positive samples sent to
the NIC for subtyping, 42 (60%) were A(H3N2) (median age,
13 months [range, 0–134 months]), 10 (14%) were A(H1N1)
(median age, 21 months [range, 4–127 months]), and 4 (6%)
were A(H1N1)pdm09 (median age, 31 months [range,
17–43 months]), with 14 failing to subtype (7 were uncon-
ﬁrmed as inﬂuenza A virus). Among outpatients aged
<13 years who presented with URTI, 7 had A(H3N2), 3 had A
(H1N1), and 0 had A(H1N1)pdm09. The distribution of sub-
types over time is shown in Figure 2. A(H3N2) circulated in
all years, and A(H1N1) was conﬁned to 2007; A(H1N1)
pdm09 occurred in late 2009 and again in late 2010.
The age distributions of diagnoses of inﬂuenza A, B, or C
virus infection over the 4 years of surveillance are shown in
Supplementary Figure 1 and follow a similar pattern (Supple-
mentary Figure 1A), with around 50% of cases in infants (46%
had inﬂuenza A virus infection, 47% had inﬂuenza B virus in-
fection, and 66% had inﬂuenza C virus infection; P = .632).
The proportion of inpatients with pneumonia who were found
to be inﬂuenza positive showed a trend for increase with in-
creasing age (Supplementary Figure 1B). In the case of inﬂu-
enza A virus infection, the trend was signiﬁcant: 1.7% of
children aged 0–2 months had inﬂuenza A virus infection,
compared with >5% of children aged ≥24 months (P = .005).
Figure 1. Temporal distribution, by quarter, of molecular diagnoses of
inﬂuenza A virus infection (dark bars) and inﬂuenza B virus infection
(light bars) in nasopharyngeal samples collected from children with
severe or very severe pneumonia who were admitted to Kiliﬁ District
Hospital, 2007–2010. Also, on the same axis are shown the quarterly
number of admissions with bacteremia (x markers) and S. pneumoniae
(o markers). The numbers of nasopharyngeal swab specimens collected
each quarter are shown on the secondary Y axis (triangle markers). B,
Monthly weather patterns averaged during 2007–2010.
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Clinical Characteristics and Disease Severity
Analysis of the association between a diagnosis of infection
with any inﬂuenza virus and components of a set of severity
features yielded an increased odds of hypoxia among children
with inﬂuenza, compared with those without inﬂuenza (age-
adjusted OR, 1.78; 95% CI, 1.04–1.96). No other severity
feature was signiﬁcantly associated with inﬂuenza (Supple-
mentary Table 1). There were 4 deaths (age range, 7–32
months) among the 99 inpatients with inﬂuenza; one was
infected with inﬂuenza A virus, 2 were infected with inﬂuenza
B virus, and 1 was infected with inﬂuenza C virus. Three
were positive for HIV antibody, severely malnourished
(weight-for-age Z score, ≤4), and had a discharge diagnosis
including immunosuppression, and 1 inpatient (who was in-
fected with inﬂuenza A virus) had chronic heart disease.
DISCUSSION
Our study identiﬁed all 3 inﬂuenza viruses in circulation in
this rural coastal Kenya location among patients hospitalized
with severe or very severe pneumonia and among outpatients
with URTI. However, the prevalence of infection with any in-
ﬂuenza virus was low among inpatients with severe or very
severe pneumonia (4.9%) and among outpatients with URTI
(3.9%). Inﬂuenza A virus predominated, with identiﬁcation in
3.5% of inpatients and 3.3% of outpatients with URTI. Corre-
spondingly, relative to the incidence of severe or very severe
pneumonia among hospitalized children aged <5 years (1323
cases per 100 000 per year), the incidences of inﬂuenza
(64 cases per 100 000 per year) and inﬂuenza A virus infection
(46 cases per 100 000 per year) were low. There was near
absence of inﬂuenza in the convenience sample of children
without signs of respiratory illness. Our inpatient data are con-
sistent with the results of a recent review of data on seasonal
inﬂuenza from 15 published studies in sub-Saharan Africa [1],
which reported a median prevalence of 6.0% among hospitalized
pediatric patients, with a range of 0%–16%. In the same review,
the median prevalence of inﬂuenza among outpatients with ARI
was higher than we found, at 10% (range, 1%–25%; 11 studies),
but comparisons should be cautioned because of a number of
methodological differences. Exploration of a range of severity fea-
tures and concurrent illnesses revealed hypoxia to be more com-
monly associated with inﬂuenza among hospitalized children.
Calculation of the incidence of inﬂuenza-associated severe
disease on the basis of hospital admission data is likely to under-
estimate the true burden in the community, as a result of the
relationship between healthcare access and distance from the
hospital. This is supported in the analysis, where it was shown
that the incidence of inﬂuenza-associated admissions among
children with severe or very severe pneumonia was about 70%
greater in the population proximal to the hospital. We have
previously shown a similar distance decay for severe rotavirus
diarrhea [7] and severe RSV-associated pneumonia [4] and
pneumonia and meningitis [8]. Furthermore, a previous study of
RSV among infants and young children in the HDSS revealed
that roughly 4 in 5 children identiﬁed with severe pneumonia in
the outpatient setting were not admitted to the local hospital [9].
Notwithstanding this underestimation, it is clear that the in-
cidence of inﬂuenza-associated hospital admissions is signiﬁ-
cantly lower than that associated with either rhinovirus or
RSV infection. While the etiology of rhinovirus as the causa-
tive agent of lower respiratory tract disease may be in question
[10], this is not the case for RSV, which is known to be a
major cause of infant and childhood lower bronchiolitis and
pneumonia in sub-Saharan Africa and globally [11]. While
RSV is invariably among the most prevalent viruses in chil-
dren admitted with lower respiratory tract illness, it is not
always dominant over inﬂuenza [1]. In Kenya, contemporary
data on the relative prevalence of respiratory viruses among
pneumonia-related admissions to the hospital are largely
absent. Further data are clearly needed in Kenya to gauge the
relative burden of disease due to respiratory viruses and
thereby help support future health policy planning.
In terms of seasonality, there was increased occurrence in the
third and fourth quarters of each year, most notably for inﬂuen-
za A virus infection, except in 2010. These periods are character-
istically times of lower rainfall levels (referred to locally as
“second rains”), intermediate temperatures, and relative lower
humidity. During the study period, A(H1N1)pdm09 entered
Kenya [12], and cases of A(H1N1)pdm09 infection were identi-
ﬁed in KDH from late 2010. It is possible that the introduction
of A(H1N1)pdm09 disrupted the normal pattern of A(H3N2)
activity in 2010; only A(H1N1)pdm09 was observed in the latter
quarters of 2010. Continued surveillance will reveal whether A
(H1N1)pdm09 has any long-term effect on the circulation
patterns of other inﬂuenza subtypes. However, in general, the
Figure 2. Temporal distribution, by quarter, of inﬂuenza A virus sub-
types for outpatients and inpatients combined from Kiliﬁ District, coastal
Kenya, 2007–2010.
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contribution of A(H1N1)pdm09 to the burden of hospitaliza-
tion-associated pneumonia was minimal in this setting. The
possibility exists that the burden of inﬂuenza was underestimat-
ed because of associated, but delayed, invasive bacterial disease.
However, we identiﬁed no evidence for an increased number of
admissions in which bacteria (or S. pneumoniae, in particular)
were detected in blood cultures during the quarter following
peak occurrences of inﬂuenza.
During the A(H1N1)pdm09 infection pandemic, antiviral
therapy (oseltamivir) was prescribed to children admitted to
KDH with severe acute respiratory illness on a presumptive
basis (ie, prior to laboratory conﬁrmation of inﬂuenza.) This
would not have altered the pattern of observation of inﬂuenza
described in this study, because nasopharyngeal specimens
were collected prior to treatment with the antiviral. Within
the surrounding community, A(H1N1)pdm09 vaccination was
undertaken in 2010 but was limited to target groups, including
healthcare workers, pregnant women, and patients with
chronic disease, totaling 2203 subjects (Kenya Ministry of
Health, personal communication). This number and the age
group of subjects receiving vaccine would not have altered
the pattern of A(H1N1) infection occurrence described in
this study.
Half of the inﬂuenza cases occurred in infants, and the pro-
portion of cases rapidly declined with age into older age
groups. However, we noted that within the age group that we
studied, the prevalence of inﬂuenza increased with age, sug-
gesting that relative to other causes of cases of severe or very
severe pneumonia associated with admission, those caused by
inﬂuenza decline less rapidly with age.
A limitation of the present study is the failure to recruit and
test samples from approximately 20% of eligible children. The
reasons for this have been previously described [2, 4] and were
primarily due to parental refusal and, to a lesser extent, to dis-
charge or death before sampling. Failure to recruit and test
was more common for critically ill children and for those who
died while in the hospital. This almost certainly led to an un-
derestimation of severity associated with inﬂuenza. A further
limitation of the study is that results are based only on naso-
pharyngeal samples, and we now have deﬁnitive evidence that
an oropharyngeal swab specimen provides added diagnostic
value for detecting inﬂuenza in our setting (22% increased de-
tection; 95% CI, 9–42), compared with nasopharyngeal speci-
mens alone [3]. The low prevalence of inﬂuenza viruses in this
study limits the power of the analysis to identify associations
between virus presence and speciﬁc clinical features or coin-
fections. Our study involved sampling of 2000 children; a de-
ﬁnitive investigation of clinical associations will require a
considerably larger sample size or a location with a markedly
higher incidence of inﬂuenza A virus infection. We report
very low prevalence of inﬂuenza in outpatient children
without signs of acute respiratory infection, suggesting that
inﬂuenza virus is rarely the cause of asymptomatic infection,
and the data also suggest inﬂuenza is the cause of only 4% of
URTI cases. Further interpretation of these data with regard to
the association between inﬂuenza and severe disease is unwar-
ranted since outpatient sampling was not contemporaneous
throughout the period of surveillance of hospitalized patients,
and collection was not frequency matched by age and location
within the KHDSS. We therefore await the complete results of
a larger and better-designed case-control study, which is
ongoing.
In conclusion, although the incidence of inﬂuenza was un-
derestimated in this study, it is clear that inﬂuenza contributes
only a small proportion of the total burden of hospitalization-
associated severe and very severe pneumonia among children in
this rural coastal Kenya setting. Inﬂuenza A virus is the domi-
nant inﬂuenza virus causing pediatric severe and very severe
pneumonia. A seasonal signature for inﬂuenza was evident, but
no temporal association was identiﬁed with invasive bacterial
disease. Although A(H1N1)pdm09 infection was observed, its
contribution to disease was not substantial. Hypoxia was more
frequently identiﬁed among patients with inﬂuenza, and immu-
nosuppression, severe malnutrition, or chronic heart disease
were identiﬁed in all of the 4 inﬂuenza-associated deaths. Given
the low inﬂuenza prevalence, larger studies are required to in-
vestigate associations between inﬂuenza and disease severity or
prevalent conditions, such as malaria, HIV infection, or malnu-
trition. Additional comparative studies on viral diagnoses in
severe pneumonia hospital admissions are warranted elsewhere
in Kenya. Such data may be informative to the Kenya Ministry
of Health in their assessment of the role for inﬂuenza antivirals
and vaccination in Kenya.
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